1309 related articles for article (PubMed ID: 22449442)
1. Aquaporin 4 knockdown exacerbates streptozotocin-induced diabetic retinopathy through aggravating inflammatory response.
Cui B; Sun JH; Xiang FF; Liu L; Li WJ
Exp Eye Res; 2012 May; 98():37-43. PubMed ID: 22449442
[TBL] [Abstract][Full Text] [Related]
2. Baicalein reduces inflammatory process in a rodent model of diabetic retinopathy.
Yang LP; Sun HL; Wu LM; Guo XJ; Dou HL; Tso MO; Zhao L; Li SM
Invest Ophthalmol Vis Sci; 2009 May; 50(5):2319-27. PubMed ID: 19011009
[TBL] [Abstract][Full Text] [Related]
3. High-salt loading exacerbates increased retinal content of aquaporins AQP1 and AQP4 in rats with diabetic retinopathy.
Qin Y; Xu G; Fan J; Witt RE; Da C
Exp Eye Res; 2009 Nov; 89(5):741-7. PubMed ID: 19596320
[TBL] [Abstract][Full Text] [Related]
4. Intravitreal injection of corticosteroid attenuates leukostasis and vascular leakage in experimental diabetic retina.
Tamura H; Miyamoto K; Kiryu J; Miyahara S; Katsuta H; Hirose F; Musashi K; Yoshimura N
Invest Ophthalmol Vis Sci; 2005 Apr; 46(4):1440-4. PubMed ID: 15790913
[TBL] [Abstract][Full Text] [Related]
5. Aldose reductase inhibitor fidarestat attenuates leukocyte-endothelial interactions in experimental diabetic rat retina in vivo.
Hattori T; Matsubara A; Taniguchi K; Ogura Y
Curr Eye Res; 2010 Feb; 35(2):146-54. PubMed ID: 20136425
[TBL] [Abstract][Full Text] [Related]
6. Effects of peroxisome proliferator-activated receptor gamma and its ligand on blood-retinal barrier in a streptozotocin-induced diabetic model.
Muranaka K; Yanagi Y; Tamaki Y; Usui T; Kubota N; Iriyama A; Terauchi Y; Kadowaki T; Araie M
Invest Ophthalmol Vis Sci; 2006 Oct; 47(10):4547-52. PubMed ID: 17003451
[TBL] [Abstract][Full Text] [Related]
7. Effect of endothelin dual receptor antagonist on VEGF levels in streptozotocin-induced diabetic rat retina.
Masuzawa K; Jesmin S; Maeda S; Zaedi S; Shimojo N; Miyauchi T; Goto K
Exp Biol Med (Maywood); 2006 Jun; 231(6):1090-4. PubMed ID: 16741055
[TBL] [Abstract][Full Text] [Related]
8. Downregulation of the atrial natriuretic peptide/natriuretic peptide receptor-C system in the early stages of diabetic retinopathy in the rat.
Rollín R; Mediero A; Fernández-Cruz A; Fernández-Durango R
Mol Vis; 2005 Mar; 11():216-24. PubMed ID: 15789000
[TBL] [Abstract][Full Text] [Related]
9. Altered expression of retinal occludin and glial fibrillary acidic protein in experimental diabetes. The Penn State Retina Research Group.
Barber AJ; Antonetti DA; Gardner TW
Invest Ophthalmol Vis Sci; 2000 Oct; 41(11):3561-8. PubMed ID: 11006253
[TBL] [Abstract][Full Text] [Related]
10. Expression of aquaporin 4 and Kir4.1 in diabetic rat retina: treatment with minocycline.
Zhang Y; Xu G; Ling Q; Da C
J Int Med Res; 2011; 39(2):464-79. PubMed ID: 21672350
[TBL] [Abstract][Full Text] [Related]
11. Protective effects of a coumarin derivative in diabetic rats.
Bucolo C; Ward KW; Mazzon E; Cuzzocrea S; Drago F
Invest Ophthalmol Vis Sci; 2009 Aug; 50(8):3846-52. PubMed ID: 19279317
[TBL] [Abstract][Full Text] [Related]
12. Role of alpha 4 integrin (CD49d) in the pathogenesis of diabetic retinopathy.
Iliaki E; Poulaki V; Mitsiades N; Mitsiades CS; Miller JW; Gragoudas ES
Invest Ophthalmol Vis Sci; 2009 Oct; 50(10):4898-904. PubMed ID: 19553613
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of diabetic leukostasis and blood-retinal barrier breakdown with a soluble form of a receptor for advanced glycation end products.
Kaji Y; Usui T; Ishida S; Yamashiro K; Moore TC; Moore J; Yamamoto Y; Yamamoto H; Adamis AP
Invest Ophthalmol Vis Sci; 2007 Feb; 48(2):858-65. PubMed ID: 17251488
[TBL] [Abstract][Full Text] [Related]
14. Altered expression of genes related to blood-retina barrier disruption in streptozotocin-induced diabetes.
Klaassen I; Hughes JM; Vogels IM; Schalkwijk CG; Van Noorden CJ; Schlingemann RO
Exp Eye Res; 2009 Jun; 89(1):4-15. PubMed ID: 19284967
[TBL] [Abstract][Full Text] [Related]
15. Inducible nitric oxide synthase isoform is a key mediator of leukostasis and blood-retinal barrier breakdown in diabetic retinopathy.
Leal EC; Manivannan A; Hosoya K; Terasaki T; Cunha-Vaz J; Ambrósio AF; Forrester JV
Invest Ophthalmol Vis Sci; 2007 Nov; 48(11):5257-65. PubMed ID: 17962481
[TBL] [Abstract][Full Text] [Related]
16. Intravitreal injection of erythropoietin protects against retinal vascular regression at the early stage of diabetic retinopathy in streptozotocin-induced diabetic rats.
Mitsuhashi J; Morikawa S; Shimizu K; Ezaki T; Yasuda Y; Hori S
Exp Eye Res; 2013 Jan; 106():64-73. PubMed ID: 23178551
[TBL] [Abstract][Full Text] [Related]
17. Hesperetin rescues retinal oxidative stress, neuroinflammation and apoptosis in diabetic rats.
Kumar B; Gupta SK; Srinivasan BP; Nag TC; Srivastava S; Saxena R; Jha KA
Microvasc Res; 2013 May; 87():65-74. PubMed ID: 23376836
[TBL] [Abstract][Full Text] [Related]
18. Implication of VEGF and aquaporin 4 mediating Müller cell swelling to diabetic retinal edema.
Kida T; Oku H; Horie T; Fukumoto M; Okuda Y; Morishita S; Ikeda T
Graefes Arch Clin Exp Ophthalmol; 2017 Jun; 255(6):1149-1157. PubMed ID: 28303331
[TBL] [Abstract][Full Text] [Related]
19. Glial reactivity, an early feature of diabetic retinopathy.
Rungger-Brändle E; Dosso AA; Leuenberger PM
Invest Ophthalmol Vis Sci; 2000 Jun; 41(7):1971-80. PubMed ID: 10845624
[TBL] [Abstract][Full Text] [Related]
20. An endothelin type A receptor antagonist reverses upregulated VEGF and ICAM-1 levels in streptozotocin-induced diabetic rat retina.
Masuzawa K; Goto K; Jesmin S; Maeda S; Miyauchi T; Kaji Y; Oshika T; Hori S
Curr Eye Res; 2006 Jan; 31(1):79-89. PubMed ID: 16421022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]